B Jarzab

Summary

Affiliation: Gliwice Branch
Country: Poland

Publications

  1. ncbi request reprint Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Centre of Oncology, Maria Scklodowska Curie Memorial Institute, Gliwice Branch, Gliwice, Poland
    Eur J Nucl Med Mol Imaging 30:1077-86. 2003
  2. ncbi request reprint Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
    B Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Center and Institute of Oncology, Gliwice, Poland
    Endocr Relat Cancer 12:773-803. 2005
  3. ncbi request reprint Differentiated thyroid cancer in children and adults: same or distinct disease?
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
    Hormones (Athens) 6:200-9. 2007
  4. doi request reprint Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy - a prospective study
    Aleksandra Król
    Endokrynol Pol 65:40-5. 2014
  5. doi request reprint Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling
    Bartosz Wojtas
    Endokrynol Pol 64:328-34. 2013
  6. pmc Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues
    Aleksandra Pfeifer
    Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, Gliwice 44 101, Poland
    BMC Med Genomics 6:38. 2013
  7. pmc Presentation of points of general discussion and voting among the speakers of the European Thyroid Association-Cancer Research Network (ETA-CRN) meeting in Lisbon, 2009, entitled "European comments to ATA medullary thyroid cancer guidelines"
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44 101 Gliwice, Poland
    Thyroid Res 6:S11. 2013
  8. pmc Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers - the role of Ct serum level
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44 101 Gliwice, Poland
    Thyroid Res 6:S9. 2013
  9. pmc Introduction to European comments on "Medullary Thyroid Cancer: management guidelines of the American Thyroid Association"
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44 101 Gliwice, Poland
    Thyroid Res 6:S1. 2013
  10. pmc Welcome to thyroid research
    Andrzej Lewinski
    Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
    Thyroid Res 1:1. 2008

Collaborators

Detail Information

Publications66

  1. ncbi request reprint Recombinant human TSH-aided radioiodine treatment of advanced differentiated thyroid carcinoma: a single-centre study of 54 patients
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Centre of Oncology, Maria Scklodowska Curie Memorial Institute, Gliwice Branch, Gliwice, Poland
    Eur J Nucl Med Mol Imaging 30:1077-86. 2003
    ..In conclusion, our study provides preliminary evidence that rhTSH safely and effectively aids radioiodine treatment of advanced DTC, and does so to an at least equivalent degree as does T(4) withdrawal...
  2. ncbi request reprint Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
    B Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Center and Institute of Oncology, Gliwice, Poland
    Endocr Relat Cancer 12:773-803. 2005
    ..Efforts also should be made to identify molecular signatures predicting recurrence, metastasis and mortality...
  3. ncbi request reprint Differentiated thyroid cancer in children and adults: same or distinct disease?
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
    Hormones (Athens) 6:200-9. 2007
    ..In the opinion of the authors, molecular analyses of childhood thyroid cancer may be crucial, as the clinical data have not satisfactorily answered this question...
  4. doi request reprint Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy - a prospective study
    Aleksandra Król
    Endokrynol Pol 65:40-5. 2014
    ..The aim of this study was a prospective assessment of the risk of GO exacerbation in a GD patients cohort submitted to RAI therapy for hyperthyroidism...
  5. doi request reprint Unsupervised analysis of follicular thyroid tumours transcriptome by oligonucleotide microarray gene expression profiling
    Bartosz Wojtas
    Endokrynol Pol 64:328-34. 2013
    ..In our study, we undertook an unsupervised analysis of the set of follicular thyroid tumours (adenomas (FTA) and carcinomas) to verify whether the malignant phenotype influences major sources of variability in our dataset...
  6. pmc Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues
    Aleksandra Pfeifer
    Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, Gliwice 44 101, Poland
    BMC Med Genomics 6:38. 2013
    ..The purpose of this study was to derive molecular support for differential post-operative diagnosis, in the form of a simple multigene mRNA-based classifier that would differentiate between FTC and FTA tissue samples...
  7. pmc Presentation of points of general discussion and voting among the speakers of the European Thyroid Association-Cancer Research Network (ETA-CRN) meeting in Lisbon, 2009, entitled "European comments to ATA medullary thyroid cancer guidelines"
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44 101 Gliwice, Poland
    Thyroid Res 6:S11. 2013
    ..Notwithstanding the evidence based guidelines, their final acceptation requires unrestricted discussion and consideration of differences in clinical practice and experience between countries"...
  8. pmc Timing and criteria for prophylactic thyroidectomy in asymptomatic RET carriers - the role of Ct serum level
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44 101 Gliwice, Poland
    Thyroid Res 6:S9. 2013
    ....
  9. pmc Introduction to European comments on "Medullary Thyroid Cancer: management guidelines of the American Thyroid Association"
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 15, 44 101 Gliwice, Poland
    Thyroid Res 6:S1. 2013
    ..It is explained why it has been decided to publish the manuscripts within the supplement - to document voices from the discussion and popularize them...
  10. pmc Welcome to thyroid research
    Andrzej Lewinski
    Department of Endocrinology and Metabolic Diseases, Medical University of Lodz, Lodz, Poland
    Thyroid Res 1:1. 2008
    ....
  11. pmc Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi
    Aleksandra Kukulska
    Department of Nuclear Medicine and Endocrine Oncology, M, Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
    Thyroid Res 3:9. 2010
    ....
  12. pmc The prognostic value of tumor markers doubling times in medullary thyroid carcinoma - preliminary report
    Tomasz Gawlik
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland
    Thyroid Res 3:10. 2010
    ..Previous reports concluded that the Ct and CEA DT have prognostic value in MTC patients...
  13. pmc Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal
    Magdalena Chechlinska
    Department of Immunology, Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology, Warsaw, Poland
    BMC Genomics 10:261. 2009
    ..We aimed to study gene expression profile of primary and immortalised IL-2-dependent human T cells forced to exit the cell cycle by growth factor withdrawal, before apoptosis could be evidenced...
  14. ncbi request reprint Molecular changes in thyroid neoplasia
    B Jarzab
    Dept of Nuclear Medicine and Endocrine Oncology, Clinic of Oncological Surgery, Maria Skłodowska Curie Memorial Institute, Gliwice, Poland
    Folia Histochem Cytobiol 39:26-7. 2001
    ..Our own data speak against this hypothesis. We noted a high frequency of RET/PTC3 mutations in a group of Polish children with papillary thyroid carcinoma, regarded as sporadic cancer...
  15. ncbi request reprint [Indications for adjuvant therapy of thyroid cancer with radioiodine therapy]
    B Jarzab
    Zakładu Medycyny Nuklearnej i Endokrynologii Onkologicznej, Centrum Onkologii Instytut im M Skłodowskiej Curie, Oddział w Gliwicach
    Wiad Lek 54:254-65. 2001
    ..However, a gradual decrease of postoperative 131I uptake has been observed, thus, this upper limit is probably to be lowered in future...
  16. pmc 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study
    Daria Handkiewicz-Junak
    Department of Nuclear Medicine, Maria Sklodowska Curie Memorial Institute, Gliwice Branch, Wybrzeza Armii Krajowej 14, 44 100 Gliwice, Poland
    Thyroid Res 2:8. 2009
    ..The re-differentiating effect of RA was evaluated by serum thyroglobulin (Tg) monitoring before and after cessation of RA treatment and by qualitative analysis of iodine uptake on the post-therapeutic whole body scan (rxWBS)...
  17. ncbi request reprint Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients
    M Wiench
    Departments of Nuclear Medicine and Endocrine Oncology, Center of Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice, Poland
    J Clin Oncol 19:1374-80. 2001
    ..The extended analysis of all known RET proto-oncogene mutation sites is obligatory in patients younger than 45 years at diagnosis, but we also see the need to analyze the impact of rarer mutations in older patients...
  18. ncbi request reprint RET polymorphisms in codons 769 and 836 are not associated with predisposition to medullary thyroid carcinoma
    Małgorzata Wiench
    Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska Curie Memorial Institute, 44 101 Gliwice, Poland
    Cancer Detect Prev 28:231-6. 2004
    ..We conclude that in Polish patients polymorphisms at RET codons 769 and 836 are not associated with medullary thyroid carcinoma...
  19. ncbi request reprint [Early evaluation of treatment effectiveness using 131I iodine radiotherapy in patients with differentiated thyroid cancer]
    M Gawkowska-Suwińska
    Zakładu Medycyny Nuklearnej i Endokrynologii Onkologicznej, Centrum Onkologii Instytut im M Skłodowskiej Curie, Oddział w Gliwicach
    Wiad Lek 54:278-88. 2001
    ..075). There was a correlation between uptake before and after ablation in 30 mCi group, which was not seen present in 60 mCi group. CONCLUSION: For the ablation of thyroid remnants 60 mCi should be considered as a standard dose...
  20. ncbi request reprint The genetic background of medullary thyroid carcinoma in young patients
    M Wiench
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Memorial Institute, Gliwice, Poland
    Folia Histochem Cytobiol 39:163-4. 2001
    ..Our results speak in favour that the polymorphism in RET codon 769 and 836 may also be a factor predisposing to the development of MTC in young age...
  21. ncbi request reprint [Proto-oncogene RET somatic mutations in medullary thyroid carcinoma]
    M Wiench
    Zakładu Medycyny Nuklearnej i Endokrynologii Onkologicznej, Centrum Onkologii Instytut im M Skłodowskiej Curie, Oddział w Gliwicach
    Wiad Lek 54:415-21. 2001
    ..The aim of the study was to introduce the RET somatic mutations analysis in tumor tissue as well as to evaluate their types and frequencies in postoperative specimens of MTC patients treated in the Center of Oncology in Gliwice...
  22. ncbi request reprint [Consequences of clinical genetic analysis of RET proto-oncogene]
    J Włoch
    Kliniki Chirurgii Onkologicznej, Centrum Onkologii Instytut im M Skłodowskiej Curie, Oddział w Gliwicach
    Wiad Lek 54:406-14. 2001
    ....
  23. ncbi request reprint [Recombinant human TSH stimulation in radioiodine treatment of disseminated differentiated thyroid cancer--update of current and our own experiences]
    Kornelia Hasse-Lazar
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
    Endokrynol Pol 57:445-50. 2006
    ..Generally, rhTSH was very well tolerated and treatment results were comparable to those achieved with thyroid hormone withdrawal...
  24. ncbi request reprint [Rearrangement of the RET gene in papillary thyroid carcinoma]
    M Wiench
    Zakładu Medycyny Nuklearnej i Endokrynologii Onkologicznej, Instytut im M Skłodowskiej Curie Oddział w Gliwicach
    Wiad Lek 54:64-71. 2001
    ..RET/PTC3 seems to be associated with solid/follicular variant PTC and short latency period (it is found more frequently in children) whereas RET/PTC1--with classic PTC variant and long latency...
  25. ncbi request reprint Corticotropin releasing hormone (CRH) increases beta-endorphin (beta-end like) concentration in cerebrospinal fluid of rats with vasospasm following subarachnoid hemorrhage
    S Henryk
    Department of Neurosurgery and Neurotraumatology in Bytom, Poland
    J Physiol Pharmacol 50:419-28. 1999
    ..The obtained results indicate that CRH increases neuroendocrine changes induced by SAH, probably by an activation of immune cells involved in the patomechanism of chronic vasospasm...
  26. ncbi request reprint Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer
    Daria Handkiewicz-Junak
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
    J Nucl Med 48:879-88. 2007
    ....
  27. ncbi request reprint [Completion total thyroidectomy in children with differentiated thyroid cancer]
    Daria Handkiewicz-Junak
    Nuclear Medicine and Endocrine Oncology Department, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice
    Endokrynol Pol 57:356-61. 2006
    ..Especially the need for completion operation is questioned in young patients. Our objective was to examine the rate of residual neoplastic disease after non radical initial operation...
  28. doi request reprint Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions
    Daria Handkiewicz-Junak
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Wybrzeze Armii Krajowej 14, 44 100 Gliwice, Poland
    Mol Cell Endocrinol 322:8-28. 2010
    ..Considering this, in the review we summarize the present status of knowledge on other prognosis-related gene expression changes in papillary and follicular cancer and relate them to he tumor's biology...
  29. ncbi request reprint Germinal mutations of RET, SDHB, SDHD, and VHL genes in patients with apparently sporadic pheochromocytomas and paragangliomas
    Aleksandra Krawczyk
    Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Poland
    Endokrynol Pol 61:43-8. 2010
    ..Clinical presentation can sometimes be atypical and does not always allow proper diagnosis. In such situations, DNA analysis can be helpful, especially when the pheochromocytoma is the first and only symptom...
  30. ncbi request reprint Urinary iodine in patients with differentiated thyroid cancer (DTC) during L-thyroxine treatment
    Barbara Michalik
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology, Gliwince Branch, Gliwice, Poland
    Endokrynol Pol 61:458-61. 2010
    ..Urinary iodine concentrations were analyzed in the morning urine samples of patients with differentiated thyroid cancer (DTC)...
  31. ncbi request reprint Treatment with sorafenib in advanced thyroid cancer - a case report
    Jolanta Krajewska
    Nuclear Medicine and Endocrine Oncology Department, Maria Skłodowska Curie Memorial Cancer Centre and Institute of Oncology, Gliwice Branch, Poland
    Endokrynol Pol 61:492-6. 2010
    ..We present this case to document no adverse effects of therapy with sorafenib in a patient with brain DTC metastases. Sorafenib therapy was only short-term, but no progression occurred in this time...
  32. ncbi request reprint [Histopathological diagnosis of thyroid cancer in a multicenter trial]
    Dariusz Lange
    Comprehensive Cancer Center, MSC Memorial Institute, Gliwice Branch, Gliwice
    Endokrynol Pol 57:336-42. 2006
    ....
  33. ncbi request reprint BRCA1-related gene signature in breast cancer: the role of ER status and molecular type
    Katarzyna Marta Lisowska
    Department of Tumor Biology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Gliwice, Poland
    Front Biosci (Elite Ed) 3:125-36. 2011
    ..Thus, in the molecular studies of hereditary breast cancer, BRCA1 promoter methylation should be recognized and considered together with gene mutation...
  34. ncbi request reprint [131I-MIBG therapy in the treatment of pheochromocytoma in children--own experiences]
    Kornelia Hasse-Lazar
    Zakład Medycyny Nuklearnej i Endokrynologii Onkologicznej, Centrum Onkologii Instytut im M Skłodowskiej Curie, Oddział w Gliwicach
    Endokrynol Pol 59:235-40. 2008
    ..The presented data confirm effectiveness and acceptable tolerance of 131I-MIBG treatment in pheochromocytoma, what is very important in pediatric patients...
  35. ncbi request reprint Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer -- a hospital based study
    D Handkiewcz-Junak
    Department of Nuclear Medicine and Oncological Endocrinology, Maria Sklodowska Curie Memorial Cancer Centre and Institute of Oncology, Gliwice, Poland
    Neoplasma 53:67-72. 2006
    ..Simultaneously, no increased risk of other malignant neoplasm was observed in the differentiated cancer families...
  36. pmc A multi-gene approach to differentiate papillary thyroid carcinoma from benign lesions: gene selection using support vector machines with bootstrapping
    Krzysztof Fujarewicz
    Systems Engineering Group, Institute of Automatic Control, Silesian University of Technology, 44 100 Gliwice, Poland
    Endocr Relat Cancer 14:809-26. 2007
    ..The highest ranking gene, metallophosphoesterase domain-containing protein 2, achieved 96.7% of the maximum BBFR score...
  37. ncbi request reprint Gene expression profile of papillary thyroid cancer: sources of variability and diagnostic implications
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland
    Cancer Res 65:1587-97. 2005
    ..We indicate and separate the confounding variability related to the immune response. Finally, we propose a potent molecular classifier able to discriminate between PTC and nonmalignant thyroid in more than 90% of investigated samples...
  38. ncbi request reprint [Gene expression analysis by DNA microarray in papillary thyroid cancer]
    Elżbieta Gubała
    Department of Nuclear Medicine and Endocrine Oncology, Clinic of Oncologic Surgery, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, Poland
    Endokrynol Pol 56:752-7. 2005
    ..FN1 and TIMP1 expression were detected in normal tissue but markedly increased in papillary thyroid cancer. Among these 3 genes DPP4 seems to be the best molecular marker for papillary thyroid cancer...
  39. ncbi request reprint [DNA microarrays and papillary thyroid carcinoma gene expression profile]
    Barbara Jarzab
    Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
    Endokrynol Pol 56:293-301. 2005
    ..With this background recent results of papillary thyroid carcinoma analysis with DNA microarrays are presented...
  40. ncbi request reprint Application of Bayesian networks for inferring cause-effect relations from gene expression profiles of cancer versus normal cells
    Andrzej Polanski
    Department of Computer Science, Silesian University of Technology, Akademicka 16, 44 100 Gliwice, Poland
    Math Biosci 209:528-46. 2007
    ..Also predictions of our BN models are coherent with the set of putative causes and effects constructed based on our data set of papillary thyroid cancer...
  41. ncbi request reprint Use of monoclonal anti-EGFR antibody in the radioimmunotherapy of malignant gliomas in the context of EGFR expression in grade III and IV tumors
    Zbigniew Wygoda
    Department of Nuclear Medicine and Endocrine Oncology, Maria Skłodowska Curie Memorial Institute and Center of Oncology, Gliwice, Poland
    Hybridoma (Larchmt) 25:125-32. 2006
    ..We also recommend individual confirmation of EGFR expression in further anti-EGFR radioimmunotherapy trials...
  42. ncbi request reprint [Gene expression profile of medullary thyroid carcinoma--preliminary results]
    Małgorzata Oczko-Wojciechowska
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
    Endokrynol Pol 57:420-6. 2006
    ..The aim of this study was to analyze gene expression pattern of MTC by high density oligonucleotide microarray...
  43. ncbi request reprint Interaction of HLA-DRB1 alleles with CTLA-4 in the predisposition to Graves' disease: the impact of DRB1*07
    Dorota Kula
    Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice, Branch, Poland
    Thyroid 16:447-53. 2006
    ..HLA-DRB1*03 (risk allele) and DRB1*07 (protective allele) were analyzed in this aspect, the linked TNF G(-308)A polymorphism was also considered...
  44. ncbi request reprint Post-surgical use of radioiodine (131I) in patients with papillary and follicular thyroid cancer and the issue of remnant ablation: a consensus report
    Furio Pacini
    University of Siena, Siena, Italy
    Eur J Endocrinol 153:651-9. 2005
    ..To determine, based on published literature and expert clinical experience, current indications for the post-surgical administration of a large radioiodine activity in patients with differentiated thyroid cancer...
  45. ncbi request reprint [Anaplastic thyroid carcinoma in a 14-year-old boy]
    Mieczysław Szalecki
    Oddział Endokrynologiczno Diabetologiczny Wojewódzkiego Specjalistycznego Szpitala Dzieciecego w Kielcach, Kielce
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw 11:43-6. 2005
    ..We report a case of anaplastic cancer of thyroid in 14-year-old male. The diagnosis was supported on: pace of changes, clinical image, disease course, no effect of therapy, histopathological examination...
  46. ncbi request reprint rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review
    Markus Luster
    Department of Nuclear Medicine, University of Wurzburg, Josef Schneider Str 2, 97080 Wurzburg, Germany
    Endocr Relat Cancer 12:49-64. 2005
    ....
  47. ncbi request reprint Analysis of nm23-H1 protein immunoreactivity in follicular thyroid tumors
    Tomasz Ferenc
    Department of Biology and Genetics, Medical University, Lodz
    Pol J Pathol 55:149-53. 2004
    ..It can be concluded that highly positive immunoreaction for the nm23-H1 protein in the cells of carcinomas (FTCs) and microfollicular adenomas indicates for a high proliferation rate of these tumors...
  48. ncbi request reprint Analysis of P161NK4A protein expression in follicular thyroid tumors
    Tomasz Ferenc
    Department of Biology and Genetics, Medical University, Lodz
    Pol J Pathol 55:143-8. 2004
    ....
  49. pmc Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma
    Krystian Jazdzewski
    Human Cancer Genetics Program, Comprehensive Cancer Center, Ohio State University, 850 Biomedical Research Tower, 460 West 12th Avenue, Columbus, OH 43210, USA
    Proc Natl Acad Sci U S A 105:7269-74. 2008
    ..Preliminary evidence suggests that these effects are mediated through target genes whose expression is affected by the SNP status...
  50. ncbi request reprint [Optimization of 131I ablation in patients with differentiated thyroid carcinoma: comparison of early outcomes of treatment with 100 mCi versus 60 mCi]
    Aleksandra Kukulska
    Department of Nuclear Medicine and Endocrine Oncology Comprehensive Cancer Center and M Sklodowska Curie Memorial Institute of Oncology, Branch Gliwice, Gliwice
    Endokrynol Pol 57:374-9. 2006
    ..The aim of this study was to compare the early outcomes between two groups of patients with differentiated thyroid carcinoma (DTC) who received 60 or 100 mCi of (131)I for remnant ablation...
  51. ncbi request reprint Analysis of P53 and P21WAF1 proteins expression in follicular thyroid tumors
    Tomasz Ferenc
    Department of Biology and Genetics, Medical University, Lodz
    Pol J Pathol 55:133-41. 2004
    ....
  52. ncbi request reprint Follow-up and management of differentiated thyroid carcinoma: a European perspective in clinical practice
    Martin Schlumberger
    service de Medicine Nucleaire, Institut Gustave Roussy, 94805 Villejuif, France
    Eur J Endocrinol 151:539-48. 2004
    ..We also offer expanded and additional comments on various issues in the management of DTC...
  53. ncbi request reprint Follow-up of low-risk patients with differentiated thyroid carcinoma: a European perspective
    Martin Schlumberger
    Institut Gustave Roussy, Villejuif, France
    Eur J Endocrinol 150:105-12. 2004
    ..We sought to develop an improved protocol for the follow-up of low-risk patients with DTC based on the findings of recent studies...
  54. ncbi request reprint Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors
    Tomasz Ferenc
    Department of Biology and Genetics, Medical University, Lodz
    Pol J Pathol 56:27-35. 2005
    ..217; p = 0.105). Our results confirm the existence of mutual regulation mechanisms of Rb and cyclin D1 protein expressions, which are observed in cells from various carcinomas...
  55. ncbi request reprint A study of thyroglobulin concentration in the thyroid and serum of patients with different thyroid disorders
    Agata Czarnywojtek
    Department of Endocrinology, Institute of Internal Medicine, University of Medical Sciences, Poznan, Poland
    Arch Immunol Ther Exp (Warsz) 50:143-8. 2002
    ..The Tg concentrations in serum and in thyroid protein extracts were evaluated by fluoroimmunometric assay. Statistical analysis was carried out with the help of the computing programmes...
  56. ncbi request reprint Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1
    Birke Bausch
    Department of Neurology, University Medical Center Freiburg, Germany
    J Clin Endocrinol Metab 92:2784-92. 2007
    ..Because of the low prevalence of pheochromocytoma in NF1, we ascertained subjects by pheochromocytoma that also had NF1 in the hope of describing the germline NF1 mutational spectra of NF1-related pheochromocytoma...
  57. ncbi request reprint Perspectives and limitations of microarray-based gene expression profiling of thyroid tumors
    Markus Eszlinger
    III Medical Department, University of Leipzig, Ph Rosenthal Str 27, D 04103 Leipzig, Germany
    Endocr Rev 28:322-38. 2007
    ..It also illustrates perspectives and solutions for data set integration and meta-analysis, as well as the possibilities to combine array analysis with other genetic approaches...
  58. ncbi request reprint [The importance of bisoprolol in prevention of heart left ventricular hypertrophy in patients with long term L-thyroxin suppressive therapy, after the operation of differentiated thyroid carcinoma]
    Gabriela Matuszewska
    Kliniczny Oddział Chorób Wewnetrznych i Dermatologii, Szpitala Specjalistycznego nr 2, Zabrze
    Endokrynol Pol 58:384-96. 2007
    ..The aim of this study was a prospective evaluation of left ventricular hypertrophy during L suppressive-thyroxine treatment in patients treated for differentiated thyroid carcinoma...
  59. ncbi request reprint [Endocrine tumors of the stomach and duodenum (including gastrinoma) - management guidelines (recommended by the Polish Network of Neuroendocrine Tumors)]
    Grazyna Rydzewska
    Klinka Chorob Wewnwtrznych i Gastroenterologii CSK MSWiA, Warszawa, Poland
    Endokrynol Pol 59:57-67. 2008
    ..Herein we present Polish guidelines for biochemical, pathological and localisation diagnosis, and discuss therapeutic approaches, considering endoscopic and surgical treatment, pharmacological and radionuclide therapy...
  60. ncbi request reprint [Pancreatic endocrine tumors - management guidelines (recommended by the Polish Network of Neuroendocrine Tumors)]
    Beata Kos-Kudła
    Klinka Endokrynologii Katedra Patofizjologii i Endokrynologii, Slaski Uniwersytet Medyczny, Zabrze, Poland
    Endokrynol Pol 59:68-86. 2008
    ..Antitumor therapy requires multidirectional procedure, and therefore the rules of surgical treatment, biotherapy, chemotherapy and peptide receptor radionuclide therapy are discussed...
  61. ncbi request reprint [Neuroendocrine tumors of the small intestine and the appendix - management guidelines (recommended by The Polish Network of Neuroendocrine Tumors)]
    Marek Bolanowski
    Katedra i Klinika Endokrynologii, Diabetologii i Leczenia Izotopami, Akademia Medyczna, Wroclaw, Poland
    Endokrynol Pol 59:87-96. 2008
    ..Chemotherapy is less successful in disseminated or locally advanced intestinal neuroendocrine tumors, so radioisotope therapy should be considered in each case of unresectable tumor...
  62. ncbi request reprint [Neuroendocrine tumors of the colon - management guidelines (recommended by The Polish Network of Neuroendocrine Tumors)]
    Teresa Starzynska
    Klinka Gastroenterologii PAM, Szczecin, Poland
    Endokrynol Pol 59:97-104. 2008
    ..This paper provides the consensus guidelines for management of patients with these neoplasms recommended by the Polish Neuroendocrine Tumor Network Group. Furthermore the epidemiology and clinical presentation are described...
  63. ncbi request reprint [Medullary thyroid carcinoma: from molecular studies to clinical decision]
    Jan Włoch
    Clinic of Oncologic Surgery, Maria Skłodowska Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch
    Endokrynol Pol 56:362-9. 2005
    ..Moreover, it needs to be stressed that DNA analysis results inform us not only about the necessity of further therapy, but also suggest different ways of proceeding in particular type of mutation...
  64. ncbi request reprint Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease
    Alina Kurylowicz
    Department of Endocrinology, Medical Research Center, Polish Academy of Science, Warsaw, Poland
    Thyroid 15:1119-24. 2005
    ..Recently, a functional polymorphism in the CD40 gene at position -1, C to T change (C-1T) has been identified and the C/C genotype has been reported to be associated with Graves' disease (GD)...
  65. ncbi request reprint Loss of heterozygosity in 73 human thyroid tumors
    Agnieszka Wozniak
    Department of Biology and Genetics, Medical University of Gdansk, Gdansk, Poland
    Neuro Endocrinol Lett 26:521-5. 2005
    ..For PTC, tumors negative for RET/PTC rearrangements were preferred...
  66. ncbi request reprint Meta- and reanalysis of gene expression profiles of hot and cold thyroid nodules and papillary thyroid carcinoma for gene groups
    Markus Eszlinger
    III Medical Department, University of Leipzig, Philipp Rosenthal Strasse 27, D 04103 Leipzig, Germany
    J Clin Endocrinol Metab 91:1934-42. 2006
    ..This creates the opportunity to validate results obtained from one microarray study with those from other data sets. This process requires rigorous methods for accurate comparison...